
Adapalene: Prevents clogged pores and treats inflammatory and non-inflammatory acne. Salicylic Acid: Helps unclog acne-prone skin; stronger products treat selected thickened skin lesions.


Choose for clogged pores and ongoing acne prevention; introduce gradually.
Choose for blackheads and clogged pores; use the strength labelled for that area.
Can you use both?
Both help acne but both can dry the skin. Use a salicylic acid cleanser rather than a leave-on, or alternate nights.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.












Binds retinoid receptors: Adapalene works without conversion to retinoic acid. Helps keep follicles clear: Regulates cell shedding and inflammatory pathways.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Loosens outer skin cells: Salicylic acid promotes keratin shedding. Helps clear follicular plugs: Its acne role depends on strength and vehicle.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.
Built from where each one usually sits in a routine. Introduce one at a time.
Adapalene is a medicine, not a cosmetic retinol. U.S. acne formulations include 0.1% and 0.3%; the higher strength is prescription.
0.1%
0.3%
OTC acne gel
A labeled acne treatment in the U.S. Improvement takes time; using extra product does not speed the result.
Prescription acne gel
A higher-strength formulation with comparative trial evidence. A clinician can weigh benefit against irritation.
Choosing a strength: Choose the medicine and vehicle for acne severity and tolerance. Adapalene percentages are not equivalent to retinol or retinaldehyde percentages.
Higher strengths: Dryness, peeling and irritation can occur. Do not step up strength or combine several retinoids just because improvement is slow.
Formula matters: Products combining adapalene with benzoyl peroxide have additional active ingredients and different labeling; read the whole product name.
The percentage depends on the job: 0.5–2% for OTC acne care, 20–30% in studied office peels, and up to 40% in labeled wart patches. These are different treatments, not steps to work through.
0.5–2%
1.8–3%
5–17%
20–30%
12–40%
Everyday acne care
For blackheads, whiteheads and acne in washes or leave-on products. Follow the product label; dryness or stinging can limit use.
Scalp scale
In labeled treatments for dandruff, seborrheic dermatitis or psoriasis. Helps loosen scale; follow the scalp product’s directions.
Liquid wart removers
For common or plantar warts; 17% is one labeled option. Apply only to the wart, avoiding surrounding healthy skin. Not for facial acne.
Professional office peels
A studied range for clinician-applied peels, including acne treatments. Not for routine home use. Formula, layers and contact time affect the burn risk.
Wart patches and plasters
For common or plantar warts, depending on the label; 40% is a labeled option. Treat the wart only. These are not facial skincare products.
Choosing a strength: Choose for the diagnosis, body area and product type. Facial acne care, scalp products, wart treatments and office peels are not interchangeable.
Higher strengths: High-strength peels can cause burns, scarring and lasting skin-color changes. Wart removers are not for facial or genital warts, irritated or infected skin. Do not self-treat warts with these products if you have diabetes or poor circulation.
Formula matters: The percentage alone does not show how deeply a treatment acts. The base formula, contact time, number of peel layers and whether the product is washed off all matter. Follow the specific label or clinician’s directions.
Approximate windows, not promises.
First few weeksDryness or irritation may occur; worsening is not required for benefit.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
4–8 weeksFewer new lesions may become noticeable.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
8–12 weeksReassess acne control after a consistent course.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
3–6 monthsMaintenance may help if the treatment works and remains comfortable.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
6–12 monthsContinue only if appropriate; scarring or persistent acne warrants reassessment.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
Dryness, stinging and peeling can occur, especially early in use.
May sting, peel or dry skin; avoid large areas, broken skin and known salicylate allergy without advice.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Follow the age and use restrictions on the label; OTC adapalene 0.1% is labelled for ages 12 and older in the US.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Retinoids are avoided in pregnancy and while trying to conceive.
Over-the-counter strengths on the face are generally considered acceptable, but confirm with the doctor managing your pregnancy. High-strength peels and large body areas are avoided.
On the skin. The finished product delivers adapalene in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. Binds retinoid receptors directly; it does not need conversion into retinoic acid.
Skin response. Binds retinoid receptors directly, regulating follicular cell shedding and inflammatory pathways.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
On the skin. The finished product delivers salicylic acid in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Promotes shedding of outer cells and helps clear follicular plugs; concentration and vehicle set its use.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
Choose for clogged pores and ongoing acne prevention; introduce gradually.
Guidelines and controlled acne trials support adapalene. Evidence for acne medicines should not be transferred automatically to retinol, and irritation does not indicate greater benefit.
Choose for blackheads and clogged pores; use the strength labelled for that area.
Acne guidelines give a conditional recommendation. High-strength wart treatments and 30% peels are distinct interventions; their evidence cannot justify high-strength facial home use.
Sources